You are here
Actelion re-enters transaction talks with Johnson & Johnson
SWISS biotech company Actelion has turned back to prospective bidder Johnson & Johnson (J&J) for exclusive talks about a "strategic transaction", in an about-turn that appears to sideline rival suitor Sanofi.
Actelion said in a brief statement on Wednesday that it
- CALL +65 6388 3838
- EMAIL email@example.com